APA (7th ed.) Citation

Offman, J., Muldrew, B., O’Donovan, M., Debiram-Beecham, I., Pesola, F., Kaimi, I., . . . Fitzgerald, R. C. (2018). Barrett’s oESophagus trial 3 (BEST3): Study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC cancer, 18(1), 784-16. https://doi.org/10.1186/s12885-018-4664-3

Chicago Style (17th ed.) Citation

Offman, Judith, et al. "Barrett’s OESophagus Trial 3 (BEST3): Study Protocol for a Randomised Controlled Trial Comparing the Cytosponge-TFF3 Test with Usual Care to Facilitate the Diagnosis of Oesophageal Pre-cancer in Primary Care Patients with Chronic Acid Reflux." BMC Cancer 18, no. 1 (2018): 784-16. https://doi.org/10.1186/s12885-018-4664-3.

MLA (9th ed.) Citation

Offman, Judith, et al. "Barrett’s OESophagus Trial 3 (BEST3): Study Protocol for a Randomised Controlled Trial Comparing the Cytosponge-TFF3 Test with Usual Care to Facilitate the Diagnosis of Oesophageal Pre-cancer in Primary Care Patients with Chronic Acid Reflux." BMC Cancer, vol. 18, no. 1, 2018, pp. 784-16, https://doi.org/10.1186/s12885-018-4664-3.